RIPK pathway, as a potential target, for cancer treatment - a review
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2023.
Päätekijä: | Jahan, Nusrat |
---|---|
Muut tekijät: | Chowdhury, Namara Mariam |
Aineistotyyppi: | Opinnäyte |
Kieli: | English |
Julkaistu: |
Brac University
2024
|
Aiheet: | |
Linkit: | http://hdl.handle.net/10361/22051 |
Samankaltaisia teoksia
-
A review on triple-negative breast cancer and its potential treatment
Tekijä: Niasa, Jannatul Ferdous
Julkaistu: (2023) -
A review on potential of PARP inhibitors in the treatment of prostate cancer
Tekijä: Islam, Saidul
Julkaistu: (2022) -
A comprehensive review on drug repurposing in cancer treatment
Tekijä: Sarkar, Onusree
Julkaistu: (2024) -
SHP2 inhibitors: Recent advancements and potential breakthroughs in cancer therapy
Tekijä: Meem, Manila
Julkaistu: (2023) -
Drug repurposing: potential of Antimicrobial Drugs in Breast Cancer Treatment
Tekijä: Chakraborty, Anuradha
Julkaistu: (2024)